Search bioRxiv⌕ Search

Biology subjects

Schacherl, M.

Publications and source records attributed to Schacherl, M..

3 recordsLinked to original sources

Dynamic nanoscale architecture of synaptic vesicle fusion in mouse hippocampal neurons

During neurotransmission, presynaptic action potentials trigger synaptic vesicle fusion with the plasma membrane within milliseconds. To visualize membrane dynamics before, during, and right after vesicle fusion at central synapses under near-native conditions, we developed an experimental strategy for time-resolved in situ cryo-electron tomography with millisecond temporal resolution. We coupled optogenetic stimulation with cryofixation and confirmed the stimulation-induced release of neurotransmitters via cryo-confocal microscopy of a fluorescent glutamate sensor. Our morphometric analysis of tomograms from stimulated and control synapses allowed us to characterize five states of vesicle fusion intermediates ranging from stalk formation to the formation, opening, and collapsing of a fusion pore. Based on these measurements, we generated a coarse-grained simulation of a synaptic vesicle approaching the active zone membrane. Both, our morphofunctional and computational analyses, support a model in which calcium-triggered fusion is initiated from synaptic vesicles in close proximity to the active zone membrane, whereby neither tight docking nor an induction of membrane curvature at the active zone are favorable. Numbers of filamentous tethers closely correlated to the distance between vesicle and membrane, but not to their respective fusion readiness, indicating that the formation of multiple tethers is required for synaptic vesicle recruitment preceding fusion.

neuroscience↗

Structural insights into context-dependent inhibitory mechanisms of chloramphenicol in cells

Ribosome-targeting antibiotics represent an important class of antimicrobial drugs. Chloramphenicol (Cm) is a well-studied peptidyl transfer center (PTC) binder, and growing evidence suggests it inhibits translation in a nascent peptide sequence-dependent manner. How such inhibition on the molecular scale translates to action on the cellular level remains unclear. Here, we employ cryo-electron tomography to visualize the impact of Cm inside the bacterium Mycoplasma pneumoniae. By resolving cellular Cm-bound ribosomes to 3.0 [A], we provide atomic detail on Cms coordination and interaction with natural nascent peptides and tRNAs in the PTC. We find that Cm leads to accumulation of translation elongation states that indicate ongoing futile accommodation cycles, and to extensive ribosome collisions. We thus suggest that beyond its inhibition of protein synthesis, the action of Cm may involve activation of cellular stress responses. This work exemplifies how in-cell structural biology advances understanding of mechanisms of action for extensively-studied antibiotics.

biophysics↗

Structures of active melanocortin-4 receptor--Gs-protein complexes with NDP-α-MSH and setmelanotide

The melanocortin-4 receptor (MC4R), a hypothalamic master regulator of energy homeostasis and appetite, is a G-protein coupled receptor and a prime target for the treatment of obesity. Here, we present cryo-electron microscopy structures of MC4R- Gs-protein complexes with two recently FDA-approved drugs, the peptide agonists NDP--MSH and setmelanotide, with 2.9 [A] and 2.6 [A] resolution. Together with signaling data, the complex structures reveal the agonist-induced origin of transmembrane helix (TM) 6 regulated receptor activation. In both structures, different ligand binding modes of NDP--MSH, a high-affinity variant of the endogenous agonist, and setmelanotide, an anti-obesity drug with biased signaling, underline the key role of TM3 for ligand-specific interactions and of calcium ion as a ligand-adaptable cofactor. The agonist-TM3 interplay subsequently impacts the receptor- Gs-protein interfaces, mainly at intracellular loop 2. These structures reveal mechanistic details of MC4R activation or inhibition and provide important insights into receptor selectivity that will facilitate the development of tailored anti-obesity drugs.

biochemistry↗